[
  {
    "ts": null,
    "headline": "Daniel Loeb's Strategic Moves: Danaher Corp Exit Impacts Portfolio by -5.87%",
    "summary": "Exploring the Latest 13F Filing and Investment Strategies",
    "url": "https://finnhub.io/api/news?id=c735ce564533768e85de2e20e488dd519f38ae1e83fe0d09ce684253952238c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747350937,
      "headline": "Daniel Loeb's Strategic Moves: Danaher Corp Exit Impacts Portfolio by -5.87%",
      "id": 134498821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Exploring the Latest 13F Filing and Investment Strategies",
      "url": "https://finnhub.io/api/news?id=c735ce564533768e85de2e20e488dd519f38ae1e83fe0d09ce684253952238c8"
    }
  },
  {
    "ts": null,
    "headline": "Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy",
    "summary": "FARGO, N.D. & CORALVILLE, Iowa, May 15, 2025--N of 1 therapy uniquely developed for infant with life-threatening rare metabolic disorder in six months by Aldevron and Integrated DNA Technologies.",
    "url": "https://finnhub.io/api/news?id=d9070a6f080d492a6cf01be7444f428195a5d5bc1767363fb56bb0779fcfe54b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747332420,
      "headline": "Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy",
      "id": 134483783,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "FARGO, N.D. & CORALVILLE, Iowa, May 15, 2025--N of 1 therapy uniquely developed for infant with life-threatening rare metabolic disorder in six months by Aldevron and Integrated DNA Technologies.",
      "url": "https://finnhub.io/api/news?id=d9070a6f080d492a6cf01be7444f428195a5d5bc1767363fb56bb0779fcfe54b"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp. stock outperforms competitors on strong trading day",
    "summary": "Danaher Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8787e781e51d9fd505bdc9f70107473e9114d5b89596e2de03d8d65eab729be1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747326960,
      "headline": "Danaher Corp. stock outperforms competitors on strong trading day",
      "id": 134490152,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8787e781e51d9fd505bdc9f70107473e9114d5b89596e2de03d8d65eab729be1"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)",
    "summary": "Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)",
    "url": "https://finnhub.io/api/news?id=69a12e5a10ee74031b1b3b5e05bd7bbda05a7f8ce97dbe7057cc3287bd5d1805",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747323126,
      "headline": "Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)",
      "id": 134484137,
      "image": "",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=69a12e5a10ee74031b1b3b5e05bd7bbda05a7f8ce97dbe7057cc3287bd5d1805"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Danaher Corporation Presents at BofA Securities 2025 Healthcare Conference, May-15-2025 10",
    "summary": "Presenter SpeechMichael Ryskin I'm excited to host our next session. We're joined by Danaher. I'm joined by Rainer Blair, CEO. Rainer thanks so much for being here.Presenter SpeechRainer Blair Good...",
    "url": "https://finnhub.io/api/news?id=399c5a269f340bc55a465ec04f86be3b2cf181c0803c1ac66b5485aa1ffb95b5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747318820,
      "headline": "Transcript : Danaher Corporation Presents at BofA Securities 2025 Healthcare Conference, May-15-2025 10",
      "id": 134483069,
      "image": "",
      "related": "DHR",
      "source": "Finnhub",
      "summary": "Presenter SpeechMichael Ryskin I'm excited to host our next session. We're joined by Danaher. I'm joined by Rainer Blair, CEO. Rainer thanks so much for being here.Presenter SpeechRainer Blair Good...",
      "url": "https://finnhub.io/api/news?id=399c5a269f340bc55a465ec04f86be3b2cf181c0803c1ac66b5485aa1ffb95b5"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Research Tools & Consumables Earnings: Danaher (NYSE:DHR) Impresses",
    "summary": "Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its peers.",
    "url": "https://finnhub.io/api/news?id=72e67a9879cf04bbec5bb2a0d379d021c4dcdfad5d49afd5af791d19ec520df9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747280155,
      "headline": "Q1 Research Tools & Consumables Earnings: Danaher (NYSE:DHR) Impresses",
      "id": 134465742,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its peers.",
      "url": "https://finnhub.io/api/news?id=72e67a9879cf04bbec5bb2a0d379d021c4dcdfad5d49afd5af791d19ec520df9"
    }
  }
]